Pandemic Timeline

Category: Patents

Salk Institute and University of Utah file patent US5969096: Conotoxin peptides

A paralytic peptide, ψ-conotoxin Piiie has been purified and characterized from Conus purpurascens venom. Electrophysiological studies indicate that the peptide inhibits the nicotinic acetylcholine receptor (nAChR). However, the peptide does not block the binding of α-bungarotoxin, a competitive nAChR antagonist. Thus, ψ-conotoxin Piiie appears to inhibit the receptor at a site other than the acetylcholine-binding site. As ascertained by…

UNC Chapel Hill files patent US7279327: Methods for producing recombinant coronavirus

A helper cell for producing an infectious, replication defective, coronavirus (or more generally nidovirus) particle cell comprises (a) a nidovirus permissive cell; (b) a nidovirus replicon RNA comprising the nidovirus packaging signal and a heterologous RNA sequence, wherein the replicon RNA further lacks a sequence encoding at least one nidovirus structural protein; and (c) at…

Sequoia Pharmaceuticals files patent US7151163: Antiviral agents for the treatment, control and prevention of infections by coronaviruses

The invention provides compositions and methods that are useful for preventing and treating a coronavirus infection in a subject. More specifically, the invention provides peptides and conjugates and pharmaceutical compositions containing those peptides and conjugates that block fusion of a coronavirus, such as the SARS virus, to a target cell. This blocking mechanism prevents or…

Ablynx files patent US9193780: Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases

The present invention relates in part to amino acid sequences that are directed against and/or that can specifically bind to an envelope protein of a virus, as well as to compounds or constructs, and in particular proteins and polypeptides, that comprise or essentially consist of one or more such amino acid sequences. — Patent US9193780B2…

Zale et al file patent US20100216804: Long Circulating Nanoparticles for Sustained Release of Therapeutic Agents

The present disclosure is directed in part to a biocompatible nanoparticle composition comprising a plurality of non-colloidal long circulating nanoparticles, each comprising a α-hydroxy polyester-co-polyether and a therapeutic agent, wherein such disclosed compositions provide a therapeutic effect for at least 12 hours. — Patent US20100216804A1   “As you read through a patent, what you’ll find,…

Wichita State University files patent US20120265001: Composite magnetic nanoparticle drug delivery system

A composite magnetic nanoparticle drug delivery system provides targeted controlled release chemotherapies for cancerous tumors and inflammatory diseases. The magnetic nanoparticle includes a biocompatible and biodegradable polymer, a magnetic nanoparticle, the biological targeting agent human serum albumin, and a therapeutic pharmaceutical composition. The composite nanoparticles are prepared by oil-in-oil emulsion/solvent evaporation and high shear mixing.…

Genyous Biomed files patent AU2011323155: Combination therapy for prostate cancer using botanical compositions and bicalutamide

Botanical compositions comprising non-alcoholic organic extracts of Ganoderma lucidum, Salvia miltiorrhiza, and Scutellaria barbata for use in conjunction with bicalutamide therapy fpr cancer therapy, are provided. Methods for treatment or therapy of prostate cancer in a human is provided, the method comprising: administering an effective amount of a botanical composition that is effective for reducing…

Life Technologies files patent US20120228565: Method for preparing surface-modified semiconductive and metallic nanoparticles having enhanced dispersibility in aqueous media

Water-dispersible nanoparticles are prepared by applying a coating of a multiply amphipathic dispersant to the surface of a hydrophobic nanoparticle comprised of a semiconductive or metallic material. The multiply amphipathic dispersant has two or more hydrophobic regions and two or more hydrophilic regions, and is typically polymeric. Preferred polymeric dispersants are comprised of (1) a…

Austen Heinz files patent US9121825: Methods and apparatuses for MEMs based recovery of sequence verified DNA

A method of retrieving sequence-verified deoxyribonucleic acid (DNA) includes positioning a sequence-verified DNA molecule on a microelectromechanical systems (MEMS) substrate. The MEMS substrate includes an electrostatic actuator and the sequence-verified DNA molecule is positioned adjacent to a moving element. The method also includes applying a voltage between the moving element and a stator to cause…

Tsinghua University, Hon Hai Precision Industry file patent US20130251618: Method for making semiconducting single wall carbon nanotubes

A method for making semiconducting single walled carbon nanotubes (SWCNTs) includes providing a substrate. A single walled carbon nanotube film including a plurality of metallic SWCNTs and semiconducting SWCNTs is located on the substrate. A macromolecule material layer is located on the single walled carbon nanotube film to cover the single walled carbon nanotube film.…

MIT files for patent US9539210: Vaccine nanotechnology

The present invention provides compositions and systems for delivery of nanocarriers to cells of the immune system. The invention provides vaccine nanocarriers capable of stimulating an immune response in T cells and/or B cells, in some embodiments, comprising at least one immunomodulatory agent, and optionally comprising at last one targeting moiety and optionally at least…

AT&T files patent US10163055: Routing policies for biological hosts

Methods, systems, and products provide interfaces between intrahost networks and interhost networks within biological hosts. Neuroregional translations are performed to route communications to and from the biological hosts. Bioregional translations may also be performed to route communications to and from the biological hosts. — Patent US10163055B2 Source: Local copy. Related: Additional posts citing this video.…

Moderna files patent US9828416: Modified polynucleotides for the production of secreted proteins

The invention relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotides, primary transcripts and mmRNA molecules. — Patent US9828416B2 A pharmaceutical composition which has a plurality of lipid nanoparticles that has a mean particle size of between 80 nm and 160 nm and contains a modified mRNA encoding a polypeptide.…

The Pirbright Institute files patent US10130701: Coronavirus

The present invention provides a live, attenuated coronavirus comprising a variant replicase gene encoding polyproteins comprising a mutation in one or more of non-structural protein(s) (nsp)-10, nsp-14, nsp-15 or nsp-16. The coronavirus may be used as a vaccine for treating and/or preventing a disease, such as infectious bronchitis, in a subject. — Patent US10130701B21 Sources:…

Moderna files patent WO2020160397: Methods of preparing lipid nanoparticles

The present disclosure provides methods of producing lipid nanoparticle (LNP) formulations and the produced LNP formulations thereof. The present disclosure also provides therapeutic and diagnostic uses related to the produced LNP formulations. — Patent WO2020160397A1 Sources: See also, on this site: Posts citing Clay Clark with Judy Mikovits in Doctor Judy Mikovits Breaks Down the…

Kim Hansik files patent KR20210028065: Physiological saline containing graphene dispersion and corona virus vaccine using the same

The present invention relates to an injection solution, a physiological saline solution, a glucose solution, and an IV, which are to be administered in a blood vessel and subcutaneous tissue of the human body for the purpose of curing a disease. A physiological saline solution containing graphene dispersed therein according to the present invention and…

Shanghai National Engineering Research Center for Nanotechnology files patent CN112220919: Nano coronavirus recombinant vaccine taking graphene oxide as carrier

The invention belongs to the field of nano materials and biomedicine, and relates to a vaccine, in particular to development of 2019-nCoV coronavirus nuclear recombinant nano vaccine. The invention also comprises a preparation method of the vaccine and application of the vaccine in animal experiments. The new corona vaccine contains graphene oxide, carnosine, CpG and…

Patent US11107588: Methods and systems of prioritizing treatments, vaccination, testing and/or activities while protecting the privacy of individuals

System and methods for anonymously selecting subjects for treatment against an infectious disease caused by a pathogen. The system comprises a plurality of electronic devices comprising instructions to generate an ID and, when in proximity of another such electronic device, one or both electronic devices transmit/receive the ID to/from the other electronic device. Then, a…

Pfizer, BioNTech file patent WO2021213945: Coronavirus vaccine

The present disclosure relates to the fields of packaging, transportation, and storage of temperature-sensitive materials, such as biological and/or pharmaceutical products. Various aspects of such packaging, transportation, and storage are provided herein for ultra-low temperature materials useful for the treatment and/or prevention of disease. The present disclosure also provides packaging materials, methods of transportation, and…

Richard Rothschild files patent US20210257004: System And Method For Diagnosing An Individual’s Health And/Or Wellness Using Enhanced Telemedicine Vital Sign Tracking

A method is provided for acquiring and transmitting biometric data (e.g., vital signs) of a user, where the data is analyzed to determine whether the user is suffering from a viral infection, such as COVID-19. The method includes using a pulse oximeter to acquire at least pulse and blood oxygen saturation percentage, which is transmitted…

Reiner Fuellmich Interviews Dr David Martin – CDC Patent Fraud

The interview cited below was conducted as part of the Stiftung Corona Ausschuss project that is expected to result in a “Nuremberg 2” trial.  Reiner Fuellmich is a lawyer for the Stiftung Corona Ausschuss project, and so this could be considered to be a deposition hearing. As Gary D. Barnett said, This recent interview between Dr. David…

Doctor finds patent evidence that jabs may contain tracking devices, are deleting and modifying genes

In my latest interview with Stew Peter’s, we discussed how the “Covid-19 vaccine” ingredients listed in the patents, reveal that all these poisonous death shots are deleting genes and genetically modifying Humans for patentability. I can vouch for the fact that these companies seek to patent humans.  I once knew someone who was using an experimental treatment for cancer. …

Moderna sues Pfizer over patents

Complaints to be filed in both United States and Germany alleging that Pfizer and BioNTech’s COVID-19 vaccine Comirnaty® unlawfully infringes patents Moderna filed between 2010 and 2016 Moderna not seeking removal of Comirnaty® from market or injunction against future sales Company not pursuing monetary damages on sales to the 92 low- and middle-income countries in…